| Financial Year |
March 31 2023 |
| Monetary Funds |
5,415,273,153.10 |
| Held-for-trading Financial Assets |
14,594,797.41 |
| Notes Receivable |
-- |
| Accounts Receivable |
2,268,468,791.25 |
| Advances to Suppliers |
408,964,149.78 |
| Other Receivables |
244,276,648.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,620,038,067.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
189,248,667.62 |
| Total Current Assets |
11,059,281,690.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
536,298,834.53 |
| Investment Properties |
65,072,855.39 |
| Fixed Assetes |
5,585,539,998.88 |
| Under-construction Projects |
1,290,525,446.35 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,188,675,135.22 |
| R&D expenses |
20,714,007.87 |
| Goodwill |
1,595,616.68 |
| Long-Term Deferred and Prepaid Expenses |
14,396,151.05 |
| Deferred Income Tax Assets |
100,723,808.34 |
| Other Non-Current Assets |
505,786,341.43 |
| Sub-Total of Non-Current Assets |
13,414,893,472.60 |
| Total Assets |
24,474,175,162.86 |
| Short-Term Loans |
6,282,626,133.85 |
| Trading Financial liabilities |
750,125.00 |
| Notes Payable |
1,370,308,006.26 |
| Accounts Payable |
1,327,930,078.14 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
124,219,879.11 |
| Taxes Payable |
189,794,574.80 |
| Interest Payable |
-- |
| Dividend Payable |
9,720,813.46 |
| Other payables |
233,207,099.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
788,899,198.07 |
| Other Current Liabilities |
31,498,908.53 |
| Sub-Total of Current Liabilities |
10,398,689,443.12 |
| Long-term Loans |
2,344,551,628.09 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
80,700,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
113,610,617.99 |
| Deferred Income Tax Liabilities |
165,247,914.29 |
| Other Non-Current Liabilities |
437,305,271.56 |
| Sub-Total of Non-Current Liabilities |
3,334,058,573.36 |
| Total Liabilities |
13,732,748,016.48 |
| Paid-In Capital(Or Share Stock) |
3,013,897,259.00 |
| Capital Surplus |
1,455,106,886.56 |
| Surplus Reserve |
526,238,785.76 |
| LESS:Treasury Stock |
41,389,548.43 |
| Undistributed Profits |
5,346,683,749.49 |
| Minority Stockholder's Interest |
427,458,058.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,313,969,087.53 |
| Owner's Equity（Stockholder's Equity） |
10,741,427,146.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
24,474,175,162.86 |
